Santosh Kottayil
Net worth: 1 M $ as of 2026-06-29
Net worth: 1 M $ as of 2026-06-29
Santosh George Kottayil is the founder of InSys Therapeutics, Inc., founded in 2002, where the titles held include President and Executive Vice President-Technology.
The current job is Director at Grace Therapeutics, Inc., starting in 2023.
Former job includes Chief Operating Officer-US at Grace Therapeutics, Inc. Education includes a doctorate from the University of Kentucky.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-07 | 494,698 ( 3.04% ) | 1 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Director/Board Member | 2023-10-09 |
| Companies | Position | End |
|---|---|---|
| GRACE THERAPEUTICS, INC. | Corporate Officer/Principal | 2023-05-07 |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Chief Executive Officer | 2021-07-31 |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Grace Therapeutics, Inc.
Grace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare and orphan diseases | Health Technology |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Designs and develops drug delivery technology and products | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions